Medical Developments International Limited (MVP) Stock Statistics & Valuation Metrics

Medical Developments International Limited has a market cap or net worth of AU$51.26M. The enterprise value is AU$27.50M.

Medical Developments International Limited has 112,658,325 shares outstanding. The number of shares has decreased by -2.65% in one year.

Medical Developments International Limited’s return on equity (ROE) is -0.90 and return on invested capital (ROIC) is -42.01%.

The current PE Ratio of Medical Developments International Limited is -0.82. Medical Developments International Limited’s PEG ratio is >-0.01.

In the last 12 months, Medical Developments International Limited had revenue of 33.15M and earned -40.99M in profits. Earnings per share was -0.46.

In the last 12 months, operating cash flow was -5.08M and capital expenditures -1.72M, giving a free cash flow of -6.79M billion.

Medical Developments International Limited pays an annual dividend of AU$0.019, resulting in a dividend yield of ―

Medical Developments International Limited upcoming earnings date is Aug 21, 2025, TBA Not Confirmed.

Medical Developments International Limited as a current ratio of 2.74, with Debt / Equity ratio of 3.87%

In the past 12 months, Medical Developments International Limited has paid 8.07M in taxes.

Medical Developments International Limited EV to EBITDA ratio is -0.89, with an EV/FCF ratio of -1.88.

Medical Developments International Limited has AU$17.62M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of -AU$15.48M billion.

Gross margin is 46.44%, with operating margin of -50.88%, and net profit margin of -123.66%.

The average price target for Medical Developments International Limited is AU$0.71, which is 11.43% higher than the current price. The consensus rating is Hold